Emerging treatment options for variant histology bladder cancer

Fed Ghali, MD, a urologic oncology fellow at the University of Washington, discusses the outlook for patients with variant histology bladder cancer and how antibody-drug conjugates may provide a new treatment option in this setting. Ghali presented the abstract, “Antibody-drug conjugates and variant histology muscle-invasive bladder cancer: are the targets present in primary and/or metastatic tumors?” at the 2022 AUA Annual Meeting (abstract PD53-09).

Related Videos
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
blur image background of corridor in hospital or clinic image | Image Credit:  © whyframeshot - stock.adobe.com
Urinary bladder | Image credit: © magicmine - stock.adobe.com
Bernard H. Bochner, MD, FACS, answers a question during a Zoom video interview
illustration of bladder cancer
Bernard H. Bochner, MD, FACS, answers a question during a Zoom interview
hospital corridor
female doctor and male patient sitting on a couch
Related Content
© 2023 MJH Life Sciences

All rights reserved.